CAPR
Capricor Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.40
+1.29%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-52.6%
Return on equity
-35.1%
Return on assets
-40.1%
Return on invested capital
0.00x
Asset turnover
-$104.0M
Cash from operations
$4.09
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026